Yahoo Malaysia Web Search

Search results

  1. AbbVie is a global biopharmaceutical company that invents and delivers innovative medicines in areas of great need. Learn more about its pipeline, focus areas, careers and responsibility in Singapore and worldwide.

    • Explore Our Company

      People. Passion. Possibilities. ®. At AbbVie, we combine...

    • About AbbVie

      We are AbbVie, a highly focused research-driven...

    • At A Glance

      At A Glance - AbbVie | Pharmaceutical Research & Development

    • Strategy

      Strategy - AbbVie | Pharmaceutical Research & Development

  2. AbbVie is a global biopharmaceutical company that combines science, expertise and passion to solve serious health issues. Learn about AbbVie's operations, products, values and contact details in Singapore.

  3. www.abbvie.com.sg › careersCareers | AbbVie

    AbbVie is a company that discovers and delivers new ways to improve people's health. Learn about their purpose, culture, benefits, and opportunities in Singapore and around the world.

  4. People. Passion. Possibilities. ®. At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. See how we’re improving health care on a global basis. ~29,000 employees.

  5. Jan 25, 2024 · This new investment will add more than 100 jobs and new biologics manufacturing capacity to AbbVie's global network. Located in Singapore's Tuas Biomedical Park, AbbVie's Singapore plant is a state-of-the-art small-molecule and biologics manufacturing facility serving markets worldwide.

  6. Apr 13, 2021 · AbbVie is a Fortune 100 company that produces medicines for various therapeutic areas and has a manufacturing plant and a regional office in Singapore. Learn how it develops its employees, embraces diversity, and contributes to the pharmaceutical sector in Singapore.

  7. Jan 26, 2024 · AbbVie broke ground on a $223 million expansion of its Singapore facility, adding new biologics capacity and 100 jobs. The investment will support AbbVie's global pipeline of immunology and oncology products.